An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Cited by (451)

Items 301–400 of 451

1. Cholesterol: A Prelate in Cell Nucleus and its Serendipity
   Nimisha Saxena, Nimai Chand Chandra · 2020 · Current Molecular Medicine
2. Interactions of Fatty Acid and Cholesterol Metabolism with Cellular Stress Response Pathways in Cancer
   Alina M. Winkelkotte, Kamal M. Al-Shami, Adriano B. Chaves‐Filho, Felix C. E. Vogel, Almut Schulze · 2024 · Cold Spring Harbor Perspectives in Medicine
3. Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death
   Y. Lucas Yamamoto, Nobuyoshi Sasaki, Kosuke Kumagai, Satoru Takeuchi, Terushige Toyooka, Naoki Otani, Kojiro Wada, Yoshitaka Narita, Koichi Ichimura, Hiroki Namba et al. · 2018 · Neurologia medico-chirurgica
4. Oroxin A from Oroxylum indicum improves disordered lipid metabolism by inhibiting SREBPs in oleic acid-induced HepG2 cells and high-fat diet-fed non-insulin-resistant rats
   Tianqi Cai, Xiaoxue Xu, Ling Dong, Shufei Liang, Meiling Xin, Tianqi Wang, Tianxing Li, Xudong Wang, Weilong Zheng, Chao Wang et al. · 2024 · Heliyon
5. Metabolism: an important player in glioma survival and development
   Ning Wang, Yiru Yuan, Tianhao Hu, Huizhe Xu, Haozhe Piao · 2024 · Discover Oncology
6. Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma
   Pierfrancesco De Domenico, Filippo Gagliardi, Francesca Roncelli, Silvia Snider, Pietro Mortini · 2025 · Journal of Neuro-Oncology
7. Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma
   Verónica Freire-Benéitez, Nicola Pomella, Thomas O Millner, Anaëlle A Dumas, Maria Victoria Niklison-Chirou, Eleni Maniati, Jun Wang, Vinothini Rajeeve, Pedro R. Cutillas, Silvia Marino · 2021 · NAR Cancer
8. RNA mutations in the moth pheromone gland
   Peng Ru, Deliang Guo · 2014 · RNA & DISEASE
9. LXR Inhibits Proliferation of Human Breast Cancer Cells through the PI3K-Akt Pathway
   Treska S. Hassan, Aida Paniccia, Vincenzo E. A. Russo, Knut Rune Steffensen · 2015 · Nuclear Receptor Research
10. Selected cholesterol biosynthesis inhibitors produce accumulation of the intermediate FF-MAS that targets nucleus and activates LXRα in HepG2 cells
    Leonardo Gatticchi, Bruno Cerra, Paolo Tommaso Scarpelli · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
11. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway
    Yongbo Zheng, Jiajia Jin, Yingying Gao · 2020 · Medical Science Monitor
12. Transcriptomic Analysis Unveils Correlations between Regulative Apoptotic Caspases and Genes of Cholesterol Homeostasis in Human Brain
    Raffaella Picco, Andrea Tomasella, Federico Fogolari, Claudio Brancolini · 2014 · PLoS ONE
13. Tumor Metabolism: A New Field for the Treatment of Glioma
    Xiaoqian Chai, Yingjie Zhang, Wen Zhang, Kuanhan Feng, Yingyu Jiang, Anran Zhu, Xiaojin Chen, Liuqing Di, Ruoning Wang · 2024 · Bioconjugate Chemistry
14. Metabolic adaptation of myeloid cells in the glioblastoma microenvironment
    Nora Essakhi, Alexandre Bertucci, Nathalie Baeza, Carole Colin, Rosario Lavignolle, Paulina A García-González, Rafael José Argüello, Aurélie Tchoghandjian, Émeline Tabouret · 2024 · Frontiers in Immunology
15. Targeting cholesterol metabolism: a promising therapy strategy for cancer
    Chun-Lan Dai, Zi-yang Qiu, Anqi Wang, Yan Hong Shen, Lijun Zhang, Xin Luan · 2025 · Acta Pharmacologica Sinica
16. Combined therapeutic potential of nuclear receptors with receptor tyrosine kinase inhibitors in lung cancer
    Peninah M. Wairagu, Kwang Hwa Park, Jihye Kim, Jong-Whan Choi, Hyun-Won Kim, Byung‐Il Yeh, Soon‐Hee Jung, Suk‐Joong Yong, Yangsik Jeong · 2014 · Biochemical and Biophysical Research Communications
17. Altered gene expression in glycolysis–cholesterol synthesis axis correlates with outcome of triple-negative breast cancer
    Pengcheng Zhong, Rong Shu, Huiwen Wu, Zhiwen Liu, Xiaoling Shen, Yingjie Hu · 2020 · Experimental Biology and Medicine
18. SREBP2/Rab11s/GLUT1/6 network regulates proliferation and migration of glioblastoma
    Chuandong Cheng, Junhong Tu, Zengchun Hu · 2022 · Pathology - Research and Practice
19. The Aurora Kinase Inhibitor TAK901 Inhibits Glioblastoma Growth by Blocking SREBP1-Mediated Lipid Metabolism
    Xiudan Zhan, Ru Qiu, Yi He · 2022 · Cancers
20. Recent advances in understanding brain cancer metabolomics: a review
    Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Raja Ganesan, Kaviyarasi Renu, Balachandar Vellingiri, Abhijit Dey, Mohamudha Parveen Rahamathulla · 2023 · Medical Oncology
21. LXRα‐mediated downregulation of EGFR suppress colorectal cancer cell proliferation
    Xiaolong Liang, Yi Lin Cao, Song Xiang · 2019 · Journal of Cellular Biochemistry
22. Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma
    Chenxing Wu, Hongwang Song, Xiaojun Fu, Shouwei Li, Tao Jiang · 2020 · BioMed Research International
23. Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour Development
    Saketh Sriram Dinavahi, Yu‐Chi Chen, Raghavendra Gowda et al. · 2022 · International Journal of Molecular Sciences
24. The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma
    Elisa Mastrantuono, Matilde Ghibaudi, Diana Matias, Giuseppe Battaglia · 2024 · Molecular Oncology
25. Lipidomics-driven drug discovery and delivery strategies in glioblastoma
    Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, Somayeh Piroozmand, Saleh Jamehdor, Amir Barzegar Behrooz, Hamid Latifi‐Navid, Mazaher Ahmadi, Stevan Pecic · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26. Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth
    Huali Su, Yaogang Zhong, Liqing He, Feng Geng, Xinmin Yin, Yongjun Kou, Chengyao Chiang, Xiaokui Molly Mo, Yunzhou Fan, Yanwei Liu et al. · 2025 · Science Advances
27. Lipids: Driving Forces in the Underlying Biology of Carcinogenesis
    Sohini Chakraborty, Anudarshini Sathish Kumar, Satarupa Banerjee · 2025 · ACS Pharmacology & Translational Science
28. Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells
    Zhongling Zhu, Shan Xu, Jing Ren · 2023 · Lipids in Health and Disease
29. Therapeutic Applications of Oxysterols and Derivatives in Age-Related Diseases, Infectious and Inflammatory Diseases, and Cancers
    Mohamed Ksila, Imen Ghzaiel, Khouloud Sassi, Amira Zarrouk, Valerio Leoni, Giuseppe Poli, Leila Rezig, Vivien Pires, Smail Meziane, Atanas G. Atanasov et al. · 2023 · Advances in experimental medicine and biology
30. Hydrogen sulfide accumulates LDL receptor precursor via downregulating PCSK9 in HepG2 cells
    Yong Chun Huang, Ke Ning, Wenwen Li · 2020 · American Journal of Physiology-Cell Physiology
31. Repurposing Clemastine to Target Glioblastoma Cell Stemness
    Michael A. Sun, Rui Ryan Yang, Heng Liu, Wenzhe Wang, Xiao Song, Bo Hu, Nathan Reynolds, Kristen Roso, Lee H. Chen, Paula K. Greer et al. · 2023 · Cancers
32. Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma
    Trang Thi Thu Nguyen, Qiuqiang Gao, Jeong-Yeon Mun, Zhe Zhu, Chang Shu, Aaron Naim, Meri Rogava, Benjamin Izar, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2024 · Cells
33. Cholesterol: The driving force behind the remodeling of tumor microenvironment in colorectal cancer
    Ke Wang, Yuanyuan Zhang, Chengshuai Si, Yuepeng Cao, Peng Shao, Pei Zhang, Nannan Wang, Guoqing Su, Jinghang Qian, Yang Liu · 2024 · Heliyon
34. Research progress of epidermal growth factor receptor in metabolic dysfunction‐associated steatotic liver disease and related diseases
    Ziwen Wang, Ze Jin, Zhi-fan Xiong · 2025 · Diabetes Obesity and Metabolism
35. SREBP1a induced PINK1-Parkin mediated mitophagy facilitates ovarian cancer progression
    S. K. Eashayan Tanbir, Sib Sankar Roy · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
36. Astrocytic functions and lipid metabolism: Correlations and therapeutic targets in Alzheimer's disease and glioblastoma
    Xu Zhang, Rongrong Gao, Liuke Yang, Youwei Zhu, Tiancheng Zhang, Xiaorong Shen, Wenwen Gu, Long Yang, Shenjie Peng · 2024 · Clinical and Translational Discovery
37. Transcriptional Analysis of Aggressiveness and Heterogeneity across Grades of Astrocytomas
    Chunjing Wang, Cory C. Funk, James A. Eddy, Nathan D. Price · 2013 · PLoS ONE
38. ATF4/TXNIP/REDD1/mTOR signaling mediates the antitumor activities of liver X receptor in pancreatic cancers
    Zhikang Chen, Xiaobo Lai, Hui Ding, Aijun Zhang, Yufei Sun, Jianhua Ling, Paul J. Chiao, Zihua Chen, Xuefeng Xia · 2022 · Cancer Innovation
39. L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling
    Chengsha Yuan, Chang-Peng Hu, Hu-Yue Zhou, Wuyi Liu, Wen-jing Lai, Ya-Feng Liu, Yue Yin, Guo-Bing Li, Rong Zhang · 2025 · Neoplasia
40. Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism
    James Wood, Salah Abdelrazig, Sergey Evseev, Catherine A. Ortori, Marcos Castellanos‐Uribe, Sean Tobias May, David A. Barrett, Mohammed Diksin, Sajib Chakraborty, Dong‐Hyun Kim et al. · 2022 · Cancers
41. Therapeutic protein PAK restrains the progression of triple negative breast cancer through degrading SREBP-1 mRNA
    Pan Hu, Peiyi Zhou, Tieyun Sun · 2023 · Breast Cancer Research
42. Targeting NPC1 in Renal Cell Carcinoma
    Rushaniya Fazliyeva, Peter B. Makhov, Robert G. Uzzo, Vladimir M. Kolenko · 2024 · Cancers
43. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells
    Yuhki Saito, Yanhong Yang, Misa Saito, Christopher Y. Park, Kosuke Funato, Viviane S. Tabar, Robert B. Darnell · 2024 · Proceedings of the National Academy of Sciences
44. Integrating lipidomics, 16S rRNA sequencing, and network pharmacology to explore the mechanism of Qikui granule in treating diabetic kidney disease mice
    Qing You, Lin Yang, Jiahui Gong · 2024 · Journal of Chromatography B
45. Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer
    Doaa S. R. Khafaga, Ghazala Muteeb, Darin W Aswa, Mohammad Aatif, Mohd Farhan, Salma Allam · 2025 · SLAS DISCOVERY
46. Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma
    Xiaofang Tan, Shuang Liu, Liangyu Yao, Guoliang Cui, Jinhui Liu, Jiayi Ding · 2022 · Journal of Oncology
47. Fasudil Increased the Sensitivity to Gefitinib in NSCLC by Decreasing Intracellular Lipid Accumulation
    Tingting Liao, Jingjing Deng, Wenjuan Chen et al. · 2022 · Cancers
48. A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease
    Debra L. Foley, Andrew James Mackinnon · 2014 · The Pharmacogenomics Journal
49. A Novel Liver X Receptor Inverse Agonist Impairs Cholesterol and Phospholipid Metabolism and Induces Apoptosis and Necroptosis in Pancreatic Ductal Adenocarcinoma Cells
    Scott Widmann, Shivangi Srivastava, Chin‐Yo Lin · 2023 · Receptors
50. Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma
    Dengfeng Lu, Fei Wang, Yayi Yang · 2025 · Heliyon
51. The roles of ATP‐binding cassette transporter A1 and its substrate cholesterol in head and neck cancers
    Fatma Şanli, Ömer Faruk Karataş · 2023 · Cell Biology International
52. Menin Maintains Cholesterol Content in Colorectal Cancer via Repression of LXR-Mediated Transcription
    Thomas E. Nyul, Keely A. Beyries, Taylor Hojnacki et al. · 2023 · Cancers
53. Advances in the study of antisense long‑stranded non‑coding RNAs in tumors (Review)
    Yifan Shao, Yuwei Dong, Jing Zhou, Zhihua Lü, Chen Chen, Xiaomin Yuan, Linhai He, Wenwen Tang, Zepeng Chen, Yuji Wang et al. · 2024 · International Journal of Oncology
54. Mitochondrial lipid metabolism in metastatic breast cancer
    Bhuban Ruidas · 2024 · Mitochondrial Communications
55. SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition
    Yaogang Zhong, Feng Geng, Huali Su, Logan Mazik, Xinmin Yin, Meixia Pan, Na Li, C. W. Chiang, Jeffrey R. Tonniges, Xiaokui Molly Mo et al. · 2026 · Science Translational Medicine
56. Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions
    Song Xu, Jun Li, Jiang Zhu, Yun-Fei Kong, Yuhang Zhou, Zi-Kun Wang, Jin Zhang · 2024 · Frontiers in Oncology
57. HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long‐term Survival in Mouse Glioma Model
    Troy A. Halseth, Anzar Mujeeb, Lisha Liu, Kaushik Banerjee, Nigel Lang, Todd Charles Hollon, Minzhi Yu, Mark Vander Roest, Ling Mei, Hongliang He et al. · 2025 · Small
58. The Contribution of Cholesterol and Squalene Synthase in Cancer: Molecular Mechanisms, Lipid Rafts and Therapeutic Approaches
    Danai Mavridi, Theodora Katavati, Angeliki P. Kourounakis · 2025 · Medicinal Research Reviews
59. Modified lipidomic profile of cancer-associated small extracellular vesicles facilitates tumorigenic behaviours and contributes to disease progression
    Jordan Fyfe, Pratibha Malhotra, Marco Falasca · 2022 · Advances in Biological Regulation
60. Advances in synthetic lethality modalities for glioblastoma multiforme
    Seidu A. Richard · 2024 · Open Medicine
61. Lipoproteins and Cancer
    J. Caryl, Kimberly D. Kimbler · 2012 · InTech eBooks
62. Hippo pathway effectors are associated with glioma patient survival, control cell proliferation and sterol metabolism through TEAD3
    Konstantin Masliantsev, Amandine Desette, Anne‐Alicia Gonzalez, Inès Garrouche, Anaïs Noblanc, Maleaume Soulard, Mathis Triquard, Serge Milin, Michel Wager, Lucie Karayan et al. · 2025 · Brain Pathology
63. Targeting cholesterol metabolism in tumor and its immune microenvironment: opportunities and challenges
    Ziyi Wang, Xinyan Li, Xiangyu Sun · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
64. Quercetin’s regulation of glucose and lipid metabolism in gestational diabetes mellitus: role of the PCSK9/LDLR axis
    Letong Hong, Shuting Xia, Niankun Chen, Zilian Wang, Zhuyu Li · 2025 · Nutrition & Metabolism
65. Targeting Metabolic Vulnerabilities in Glioblastoma: a Framework for Multi-node Combination Therapy
    Vishal Gokani, Anuhya Kotta, Venkata Repaka, Sukanya Rauniyar, Evan Noch · 2026 · Current Oncology Reports
66. Deciphering the topological landscape of glioma using a network theory framework
    Meng-Chao Yao, Yang Su, Ruiqi Xiong, Xile Zhang, Xiaomei Zhu, Yong-Cong Chen, Ping Ao · 2024 · Scientific Reports
67. EGFR inhibitor suppresses tumor growth by blocking lipid uptake and cholesterol synthesis in non-small cell lung cancer
    Byung‐Ho Rhie, Sang Hyeon Woo, Hyun‐Yi Kim et al. · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
68. Cancer Stem Cells in Glioblastoma: The Role of the mTOR Pathway
    Monica Mureb, Sabrina Zeller, Haylen Rosberger, Eris Spirollari, Mohan K Das, Simon Jeremy Hanft, Chirag D. Gandhi, Meena Jhanwar‐Uniyal · 2025 · Anticancer Research
69. Cholesterol metabolism and tumor radiotherapy
    Hao Kuang, Jia-Hua Lyu, Tao Li · 2023 · journal of nutritional oncology
70. Cancer RNome: Evolution and Sustenance
    Mansi Arora, Deepak Kaul · 2018 · Springer eBooks
71. Fructose, Another Sweet for Cancer: A Context Acting Nutrient Hypothesis
    Tomas Koltai, Larry Fliegel · 2023 · Gene Expression
72. Dynamic extracellular proximal interaction profiling reveals Low-Density Lipoprotein Receptor as a new Epidermal Growth Factor signaling pathway component
    Rasha Al Mismar, Payman Samavarchi‐Tehrani, Brendon Seale · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
73. Targeting Liver X Receptors in Cancer Drug Discovery
    Asitha Premaratne, Abhinav Bagchi, Shinjini Basu, Jan-Ακε Gustafsson, Chin‐Yo Lin · 2024 · Receptors
74. Aging-associated mechanisms and metabolic vulnerabilities in esophageal carcinoma: an integrative review
    Qiwei Liu, Zhiyu Xie, Wei Li, Mengxiang Li, Yijun Qi · 2025 · Frontiers in Cell and Developmental Biology
75. Liver-X-receptor agonism enhances T cell priming and activation to promote anti-tumor immunity
    Benjamin Nils Ostendorf, Jonathan G. Goldstein, Shuang Liu, Foster C. Gonsalves, Jana Bilanovic, Mathias Yuan, Ji-Young Kim, Christopher Rouya, Masoud F. Tavazoie, Sohail F. Tavazoie · 2026 · The Journal of Experimental Medicine
76. Enhanced delivery of low-density lipoprotein-based nanoparticles to the mouse glioblastoma using focused ultrasound as a novel therapy
    Carlos J. Brambila, Navideh Sahebi Vaighan, Ibrahim Youssef, Jaideep Chaudhary, Arnida Anwar, Robert M. Bachoo, Toral Patel, Rajiv Chopra, Ian R. Corbin · 2026 · Biomaterials
77. Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway
    Evelyn Andrades, Agustí Toll, Gustavo Deza et al. · 2023 · Life Science Alliance
78. Transcriptional and non-transcriptional roles of LXRs in cancer cells
    2015 · Receptors & Clinical Investigation
79. Highlights from the Literature
    Jason T. Huse, Roger Abounader, Benjamin W. Purow, Monika E. Hegi, Riccardo Soffietti, Kenneth Aldape · 2016 · Neuro-Oncology
80. 4-Acetylantrocamol LT3 Inhibits Glioblastoma Cell Growth and Downregulates DNA Repair Enzyme O6-Methylguanine-DNA Methyltransferase
    Shih‐Yu Lee, I‐Chuan Yen, Jang‐Chun Lin, Min-Chieh Chung, Wei‐Hsiu Liu · 2021 · The American Journal of Chinese Medicine
81. The Effects of Sterol-Related Signaling Pathways on Glioma
    Masoumeh Eslahi, Parisa Maleki Dana, Fatemeh Sadoughi, Jamal Hallajzadeh, Zatollah Asemi, Mehran Sharifi, Mohammad Alì Mansournia, Bahman Yousefi · 2021 · Nutrition and Cancer
82. Astrocyte, Lipid Metabolism in Alzheimer’s Disease and Glioblastoma
    2022
83. The HDL particle composition determines its anti-tumor activity in pancreatic cancer
    Raimund Bauer, Kristina Kührer, Florian Udonta et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
84. Lung adenocarcinoma
    Rafael Rosell · 2012
85. Correction: An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway
    2012 · Cancer Discovery
86. Identification and validation of cholesterol metabolism-related gene GNB3 as prognosis biomarker for pancreatic adenocarcinoma
    Shiwei Wu, Haibo Lei, Can Xiao · 2025 · Discover Oncology
87. Intracellular cholesterol: new functions and therapeutic approaches in NSCLC EGFR-TKI resistance
    Linjuan Wang, Yue Qiu, Xiang Huang, Shimei Zhang, Min Zhao, Qiufang Chen · 2025 · Lipids in Health and Disease
88. Bioactive Glycosylated Flavonoids Exhibiting LXR Agonist Activity from a Lauraceae Colombian Species
    Juanita Pulido Teuta, Fabián López-Vallejo, Adrián Gabriel Sandoval-Hernández, Carlos‐Eduardo Narváez‐Cuenca, Mónica Constanza Ávila Murillo · 2025 · Plants
89. Employing low-density lipoprotein-based delivery systems for the treatment of hepatocellular carcinoma
    Meghana Kolli, Tiyler Adams, Ian R. Corbin · 2025 · Nanomedicine
90. Unique protein dynamics distinguish the highly homologous LXR α and β isotypes
    Kesaban Sankar Roy Choudhuri, C. Denise Okafor · 2026 · Biophysical Journal
91. Targeting cholesterol-driven immunometabolism in cancer: from molecular circuits to clinical translation
    Qiang Ma, Bonan Chen, Tingting Li, Yanhui Lu, Xiaoguang Li · 2026 · Molecular Cancer
92. Scientists target cholesterol to treat brain tumors
    Carrie Printz · 2012 · Cancer
93. A lipid metabolism-related risk signature for patients with gliomas constructed with TCGA and CGGA data
    Dingqiang Meng, Ting Liu · 2022 · Medicine
94. Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells
    Hua-Yu Wang, Thu P. Nguyen, Alex C. Sternisha, Christopher L. Carroll, Bethany Cross, Lorraine Morlock, Noelle Sevilir Williams, Samuel K. McBrayer, Deepak Nijhawan, Jef K. De Brabander · 2024 · Journal of Medicinal Chemistry
95. Aberrant de novo cholesterogenesis: Clinical significance and implications
    Rida Rashid, Fatima Ameer, Hubert Kalbacher, Lisa Scandiuzzi, Nousheen Zaidi · 2015 · Clinica Chimica Acta
96. Lipid metabolism and signaling in cancer
    Elena Piccinin, James Mukasa Ntambi, Antonio Moschetta · 2020 · Elsevier eBooks
97. Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
    Kasper Aalbæk Kjærgaard, Sixten Harborg, Henrik Kjærulf Jensen, Signe Borgquist · 2022 · Lipids in Health and Disease
98. ZBTB18 inhibits SREBP-dependent fatty acid synthesis by counteracting CTBPs and KDM1A/LSD1 activity in glioblastoma
    Roberto Ferrarese, Annalisa Izzo, Geoffroy Andrieux, Simon Lagies, Johanna Paulina Bartmuss, Anie P. Masilamani, Alix Wasilenko, Daniela Osti, Stefania Faletti, Rana Schulzki et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
99. Cholesterol Analogs Ginsenosides Rg1 and Compound K Control Temozolomide Resistance in Glioblastoma Cells by Regulating Cholesterol Efflux and Lipid Raft Distribution
    Runze Qiu, Jingjing Zhang, Chun Ge, Yue Zhong, Qingquan Li, Yingbin Li, Hongwei Fan · 2022 · Research Square
100. Energy Landscape near Glioma Decipher the Role of Glioma Stem Cells within Glioma Hierarchy
     Mengchao Yao, Yang Su, Ruiqi Xiong, Xile Zhang, Zhu Xiao-mei, Yong-Cong Chen, Ping Ao · 2023 · bioRxiv (Cold Spring Harbor Laboratory)